Your browser doesn't support javascript.
loading
Ikos Test: New Tool for the Assessment of Semantic Knowledge in Early Alzheimer Disease.
Cejudo, Juan Carlos; Samaniego, Melissa; Almeria, Marta; Castrillo, Susana; Medina, Lidia; Gil, Domènec.
Afiliación
  • Cejudo JC; Cognitive Impairment and Dementia Unit, Hospital Sagrat Cor, Hermanas Hospitalarias, Martorell, (Barcelona), Spain.
  • Samaniego M; Cognitive Impairment and Dementia Unit, Hospital Sagrat Cor, Hermanas Hospitalarias, Martorell, (Barcelona), Spain.
  • Almeria M; Cognition and Behavior Unit, Department of Neurology, Hospital Universitari Mútua Terrassa, Terrassa (Barcelona), Spain.
  • Castrillo S; Department of Medicine, Autonomous University of Barcelona, Barcelona, Spain.
  • Medina L; RGG Sant Roc (DGPS), Drets Socials Departament, Generalitat de Catalunya, Barcelona, Spain.
  • Gil D; Cognitive Impairment and Dementia Unit, Hospital Atenció Intermedia Mutuam Güell, EAPS Mutuam Barcelona, Barcelona, Spain.
J Alzheimers Dis ; 90(1): 151-160, 2022.
Article en En | MEDLINE | ID: mdl-36093701
ABSTRACT

BACKGROUND:

Semantic memory (SM) constitutes a cognitive system that is seriously affected by Alzheimer's disease (AD). There are several tests for assessing SM, but a tool is needed to assess AD in the early stages of the illness.

OBJECTIVE:

The study aimed to create, validate, and normalize a new test to assess SM, called the Ikos test, for AD and early AD in clinical practice.

METHODS:

62 healthy adults as a control group (CG), 62 AD, and 60 amnestic mild cognitive impairment (aMCI) subdivided into a group that progresses to AD, and another group that does not progress to AD were selected. The internal consistency (IC), the construct validity (CV), and reliability between raters and the test-retest were analyzed. We used the Bayesian approach to establish the accuracy of the diagnosis of the Ikos test in AD and early AD.

RESULTS:

IC showed a Kuder-Richardson index of r = 0.945. The CV between the Ikos test and Pyramids and Palm Trees; Intraclass Correlation Coefficient (ICC) index was 0.897. The Kappa index was between 0.865 and 0.912, and the ICC index was 0.873 for the test-retest reliability. The Area Under the Curve was 0.981, sensitivity (SE) was 0.95, and specificity (SP) was 0.96 in AD/CG. In contrast, in the MCI-AD/CG group, SE = 0.77 and SP = 0.80.

CONCLUSION:

The Ikos test accomplishes the criteria of validity and reliability with high correlation indexes. Therefore, it can be considered a valid, reliable, and easily applicable tool for SM assessment in diagnosing AD and the early stages of clinical disease.
Asunto(s)
Palabras clave

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Enfermedad de Alzheimer / Disfunción Cognitiva Tipo de estudio: Diagnostic_studies / Prognostic_studies Límite: Humans Idioma: En Revista: J Alzheimers Dis Asunto de la revista: GERIATRIA / NEUROLOGIA Año: 2022 Tipo del documento: Article País de afiliación: España

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Enfermedad de Alzheimer / Disfunción Cognitiva Tipo de estudio: Diagnostic_studies / Prognostic_studies Límite: Humans Idioma: En Revista: J Alzheimers Dis Asunto de la revista: GERIATRIA / NEUROLOGIA Año: 2022 Tipo del documento: Article País de afiliación: España